drugset / Trial / NCT00297765

Optimizing Prograf® Therapy in Renal Transplant Patients

NCT00297765 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

A study to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients.

Timeline

Start
2003-01
Primary completion
—
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — —

Indications

No indication recorded.